Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

26.480
+0.3401.30%
Volume:634.94K
Turnover:16.81M
Market Cap:23.51B
PE:11.67
High:26.660
Open:26.100
Low:26.100
Close:26.140
52wk High:39.269
52wk Low:23.240
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:1.06
T/O Rate:0.21%
Dividend:1.64
Dividend Rate:6.21%
EPS(LYR):2.270
ROE:15.06%
ROA:6.59%
PB:1.40
PE(LYR):11.67
PS:1.73

Loading ...

Livzon Pharma Reports No Change in Share Capital; Confirms Public-Float Compliance for June 2026

Bulletin Express
·
Jul 02

LIVZON PHARMA Shares Surge in Late Trading Following New Drug Application Acceptance

Stock News
·
Jun 10

Livzon Pharma Unit Wins China Approval for Fertility Drug Biosimilar

MT Newswires Live
·
Jun 02

Livzon Pharmaceutical Drug Accepted for China Review

MT Newswires Live
·
Jun 02

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

LIVZON PHARMA's Recombinant Human Follitropin Injection Receives Marketing Authorization

Stock News
·
Jun 01

Livzon Pharma’s Lecankitug Injection NDA for Ankylosing Spondylitis Accepted by China NMPA

Bulletin Express
·
Jun 01

LIVZON PHARMA's Application for New Antibody Drug Receives Regulatory Acceptance

Stock News
·
Jun 01

LIVZON PHARMA Appoints Ran Yongmei as Employee Representative Director

Stock News
·
May 29

Livzon Pharma Announces Updated Board Structure and Committee Line-up

Bulletin Express
·
May 29

LIVZON PHARMA Announces Final Dividend Payout Scheduled for July 13

Stock News
·
May 29

LIVZON PHARMA Appoints Liu Daping as President

Stock News
·
May 29

Livzon Pharmaceutical Gains Strong Shareholder Backing at 2025 AGM; Confirms RMB14.30 Cash Dividend per 10 Shares

Bulletin Express
·
May 29

Insights from Day One of the Shenzhen Stock Exchange Global Investor Conference: Market Valuations Deemed Reasonable, Steady Inflows of Foreign Capital, and Chinese Assets Showcase Distinct 'Safety Premium'

Deep News
·
May 28

Livzon Pharma Maintains 887.91 million Authorised Shares; Public Float Meets HKEX Requirement in April 2026

Bulletin Express
·
May 06

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Stock News
·
Apr 25

Livzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void

Bulletin Express
·
Apr 24

Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online

Bulletin Express
·
Apr 23

Livzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares

Bulletin Express
·
Apr 23

Livzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting

Bulletin Express
·
Apr 23